Study S001059

Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07605572
Acronym: GALENOS
Study type: OBSERVATIONAL
Status: RECRUITING
Enrollment: 100
Start: 2026-03-01
Primary completion: 2026-12-31
Lead sponsor: Attikon Hospital
Conditions: Dry Eye Disease (DED); Diabete Mellitus; GLP-1; Ocular Surface; Diabetes Type 2; Cornea
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Changes in Ocular Parameters [All ophthalmological will be assessed at two time points: t0: Baseline assessment, before initiation of GLP-1 RA or GLP-1 RA/GIP therapy. t1: Follow-up assessment, 6-months after the intervention period, to evaluate changes ocular surface.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.